SeaStar Medical Holding Corporation, trading under the symbol ICU on The Nasdaq Stock Market LLC, has received a Nasdaq Staff Deficiency Letter on June 24, 2024, indicating non-compliance with the Market Value of Listed Securities (MVLS) requirement. The company's MVLS has been below the $35 million threshold for 35 consecutive business days, which is necessary for continued listing on The Nasdaq Capital Market. SeaStar Medical has until December 23, 2024, to regain compliance, with the possibility of achieving this if its MVLS closes at $35 million or more for at least ten consecutive business days before the deadline. The deficiency notice does not immediately affect the trading of SeaStar Medical's common stock. Additionally, the company has regained compliance with the Nasdaq's Minimum Bid...Show More

SeaStar Medical Holding Corporation, trading under the symbol ICU on The Nasdaq Stock Market LLC, has received a Nasdaq Staff Deficiency Letter on June 24, 2024, indicating non-compliance with the Market Value of Listed Securities (MVLS) requirement. The company's MVLS has been below the $35 million threshold for 35 consecutive business days, which is necessary for continued listing on The Nasdaq Capital Market. SeaStar Medical has until December 23, 2024, to regain compliance, with the possibility of achieving this if its MVLS closes at $35 million or more for at least ten consecutive business days before the deadline. The deficiency notice does not immediately affect the trading of SeaStar Medical's common stock. Additionally, the company has regained compliance with the Nasdaq's Minimum Bid Price Rule after a one-for-twenty-five reverse stock split on June 7, 2024, following a previous notification of non-compliance for having a closing bid price below $1.00 per share for 30 consecutive business days. The company is exploring options to address the MVLS requirement, including potentially applying for an extension or appealing to a Nasdaq Hearings Panel.